Status:
COMPLETED
COVID-19 Active Research Experience (CARE)
Lead Sponsor:
Iqvia Pty Ltd
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 Active Research Experience (CARE) is an observational, direct-to-participant, web-based, longitudinal study of adults with COVID-19 or COVID-19 like illness or who were vaccinated against COV...
Detailed Description
This is an observational, direct-to-participant, web-based, longitudinal study of adults with COVID-19 or COVID-19 like illness to better understand risk factors, symptoms, and treatments for COVID-19...
Eligibility Criteria
Inclusion
- Adult (18 years or older)
- Currently living in the US or UK
- Have regular access to a computer, smartphone or tablet and sufficient internet to support registry demands (note: this registry is designed to operate well even in regions with low bandwidth)
- Willing and able to provide informed consent
- Willing and able to follow the procedures of the study
- Participants must also meet at least one of the following conditions:
- Have COVID-19 or COVID-19 like symptoms
- Received a COVID-19 vaccine
- Potential exposure to COVID-19
Exclusion
- Unable to provide informed consent
- Unable to perform the requested study tasks and unable or unwilling to assign a proxy informant to complete the tasks
Key Trial Info
Start Date :
April 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 23 2023
Estimated Enrollment :
35278 Patients enrolled
Trial Details
Trial ID
NCT04368065
Start Date
April 2 2020
End Date
February 23 2023
Last Update
March 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IQVIA
Cambridge, Massachusetts, United States, 02139
2
IQVIA
London, United Kingdom